Depot Naltrexone Treatment of Opioid Dependent Parolees

Completed · Not applicable

Conditions studied: Opioid Dependence

In brief

This is an investigation involving the use of a long-acting, injectable form (depot) of naltrexone as a treatment for persons who have a history of opioid dependence, with up to 40 on parole/probation and 20 non-parolees. The test is a pilot study of up to 60 subjects treated with 6 months of depot naltrexone plus Psychosocial Treatment .

Key facts

Study ID
NCT00756990
Run by
University of Pennsylvania
People needed
61
Starts
2005-11-01
Expected to finish
2011-08-01
Last updated by the study team
2019-04-23

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.